About CrystalGenomics
CrystalGenomics is a company based in Seongnam-si (South Korea) founded in 2000.. The company has 80 employees as of December 31, 2024.
- Headquarter Seongnam-si, South Korea
- Employees 80 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cg Invites Co., Ltd.
-
Annual Revenue
$4.92 M (USD)48.67as on Dec 31, 2024
-
Net Profit
$-34.95 M (USD)-5.36as on Dec 31, 2024
-
EBITDA
$-23.46 M (USD)-13.22as on Dec 31, 2024
-
Latest Funding Round
$851.6 K (USD), Post-IPO
Dec 23, 2015
-
Investors
Ministry of Health and Welfare
& 1 more
-
Employee Count
80
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CrystalGenomics
CrystalGenomics is a publicly listed company on the KRX with ticker symbol 083790 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of CrystalGenomics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $851,600
-
First Round
First Round
(13 Jan 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2015 | Amount | Post-IPO - CrystalGenomics | Valuation |
investors |
|
| Jun, 2014 | Amount | Post-IPO - CrystalGenomics | Valuation |
investors |
|
| Jan, 2012 | Amount | Post-IPO - CrystalGenomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CrystalGenomics
CrystalGenomics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Ministry of Health and Welfare and Korea-Seoul Life Science Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Government entity responsible for health and welfare services in Taiwan.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CrystalGenomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CrystalGenomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Crystalgenomics Comparisons
Competitors of CrystalGenomics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Crystalgenomics
Frequently Asked Questions about CrystalGenomics
When was CrystalGenomics founded?
CrystalGenomics was founded in 2000 and raised its 1st funding round 12 years after it was founded.
Where is CrystalGenomics located?
CrystalGenomics is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
How many employees does CrystalGenomics have?
As of Dec 31, 2024, the latest employee count at CrystalGenomics is 80.
What is the annual revenue of CrystalGenomics?
Annual revenue of CrystalGenomics is $4.92M as on Dec 31, 2024.
What does CrystalGenomics do?
Crystal Genomics is a clinical stage biopharmaceutical company working on the discovery and development of novel pharmaceuticals with innovative platform technologies to address significant unmet medical needs in the areas of infectious disease, oncology, and inflammatory diseases.The Companys lead therapeutic program is Accelex, a next-generation NSAID for osteoarthritis is in NDA approval phase. Other products include CG400549 the antibiotic for MRSA and CG200745, a molecular targeted cancer therapeutic for solid tumors are in phase 2 development. Another molecular targeted cancer therapeutic CG026806 is in pre-clinical trials. It acquired Hwail Pharmaceutical on August 14, 2013 and has partnered with Daewoong Pharmaceutical for Acelex Commercialization in Korea. It also offers platform technology for drug discovery.
Is CrystalGenomics publicly traded?
Yes, CrystalGenomics is publicly traded on KRX under the ticker symbol 083790.
Who are CrystalGenomics's investors?
CrystalGenomics has 2 investors. Key investors include Ministry of Health and Welfare, and Korea-Seoul Life Science Fund.
What is CrystalGenomics's ticker symbol?
The ticker symbol of CrystalGenomics is 083790 on KRX.